Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,115

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,793

Class I recallsReasonable probability of serious health consequences

24,343

Class II recallsTemporary or medically reversible health consequences

2,887

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/so-delicious-dairy-freer-issues-voluntary-recall-salted-caramel-cluster-non-dairy-frozen-dessertPublished September 15, 2026

Most affected stateHawaii 200 recalls mention this state

State: PR ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 18, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

Download CSV

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

FDA Recall Terminated Historical recordClass II

MethylPREDNISolone Tablets, USP 16 mg, 50 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-918-18

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

MethylPREDNISolone Tablets, USP 4 mg per tablet, 21 Tablets dosepack, Rx Only, Made in India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-916-34

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

MethylPREDNISolone Tablets, USP, 4 mg, 100 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India NDC 68382-916-01

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochloride Tablets 1 mg, 90-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-199-16

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochloride Tablets 0.5 mg, 90-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-198-16

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochloride Tablets 0.25 mg, 1000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. NDC 68382-197-10

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochoride Tablets 0.25 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-197-16

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole DihydrochlorideTablets 0.125 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-16

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochloride Tablets 0.125 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-10

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Anastrozole Tablets, USP, 1 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534. NDC 68382-209-10

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ANASTROZOLE Tablets, 1 mg, Rx Only, 30-count bottle, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534 NDC 68382-209-06

by Zydus Pharmaceuticals USA Inc

Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cetirizine Oral Solution 1 mg/mL, Up & Up, Children's allergy relief, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. (118 mL) Bottle, Distributed by Target Corporation, Minneapolis, MN 55403, NDC 11673-178-04, UPC 359726178044.

by P & L Developments, LLC

Reason: cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cetirizine Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. Bottle, Distributed by C.D.M.A. Inc., Novi, MI 48376, Quality Choice, NDC 63868-430-04, UPC 635515992474.

by P & L Developments, LLC

Reason: cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cetirizine HCL Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Gluten Free, Grape Flavor, 5 mg/5mL, 4 FL. oz. Bottle, Distributed by Dolgencorp, LLC, 100 mission ridge, Goodlettsville, TN 37072, NDC 55910-878-04, UPC 359726178051.

by P & L Developments, LLC

Reason: cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Anastrozole Tablets, USP, 1mg, 30-count unit dose blisters per carton, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC 60687-112-21.

by American Health Packaging

Reason: GMP Deviations: Potential cross contamination due to cleaning procedure failure.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

QUIK-CARE Aerosol Foam Hand Sanitizer (62.5% Ethyl Alcohol), packaged in 7 oz cans, Ecolab, 370 Wabasha Street N, St. Paul, MN 55102-1390 USA, NDC 47593-490-82

by Ecolab Inc

Reason: Incorrect/undeclared excipients: Hand sanitizer was made using the wrong alcohol raw material.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Myorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules containing 3 x 10 Prescription Packs, Rx Only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forest, IL 60045, NDC 61748-304-13

by Akorn Inc

Reason: Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented), a) 15 gram (NDC 52565-019-15) and b) 50 gram (NDC 52565-019-51) tubed, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 06310

by Teligent Pharma, Inc.

Reason: Failed Impurities/Degradation Specifications
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg, Extended-Release Tablets, USP, Allergy & Congestion, 20-count box.Distributed by: Walgreen Co. 200 Wilmore Rd. Deerfield, IL 40015. Made in India UPC 3 11917 19453 0

by Sun Pharmaceutical Industries, Inc.

Reason: Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit
Published: June 26, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg/ Extended-Release Tablets, USP, Allergy & Congestion, 30-count box. Distributed by: Walgreen Co. 200 Wilmore Rd. Deerfield, IL 40015. Made in India. UPC 3 11917 19454 7

by Sun Pharmaceutical Industries, Inc.

Reason: Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit
Published: June 26, 2019
Distribution: Nationwide

View recall →

Data last updated: September 18, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.